161 related articles for article (PubMed ID: 12893026)
21. Modulation of platelet function by reactive oxygen metabolites.
Ambrosio G; Golino P; Pascucci I; Rosolowsky M; Campbell WB; DeClerck F; Tritto I; Chiariello M
Am J Physiol; 1994 Jul; 267(1 Pt 2):H308-18. PubMed ID: 8048596
[TBL] [Abstract][Full Text] [Related]
22. cGMP mediates the vascular and platelet actions of nitric oxide: confirmation using an inhibitor of the soluble guanylyl cyclase.
Moro MA; Russel RJ; Cellek S; Lizasoain I; Su Y; Darley-Usmar VM; Radomski MW; Moncada S
Proc Natl Acad Sci U S A; 1996 Feb; 93(4):1480-5. PubMed ID: 8643658
[TBL] [Abstract][Full Text] [Related]
23. L-arginine modulates aggregation and intracellular cyclic 3,5-guanosine monophosphate levels in human platelets: direct effect and interplay with antioxidative thiol agent.
Anfossi G; Russo I; Massucco P; Mattiello L; Perna P; Tassone F; Trovati M
Thromb Res; 1999 Jun; 94(5):307-16. PubMed ID: 10379819
[TBL] [Abstract][Full Text] [Related]
24. Platelet aggregation induced by the endoperoxide analogue U46619 is inhibited by polymorphonuclear leukocyte ADPase activity.
Zatta A; Pandolfo L; Caparrotta L; Prosdocimi M; Dejana E; Del Maschio A
Arterioscler Thromb; 1993 May; 13(5):696-701. PubMed ID: 8485121
[TBL] [Abstract][Full Text] [Related]
25. Calreticulin Transacetylase mediated activation of human platelet nitric oxide synthase by acetyl group donor compounds.
Kumar A; Sushama A; Manral S; Sinha R; Joshi R; Singh U; Rohil V; Prasad AK; Parmar VS; Raj HG
Nitric Oxide; 2012 Jan; 26(1):9-19. PubMed ID: 22100620
[TBL] [Abstract][Full Text] [Related]
26. Lipopolysaccharide treatment reduces rat platelet aggregation independent of intracellular reactive-oxygen species generation.
Lopes-Pires ME; Casarin AL; Pereira-Cunha FG; Lorand-Metze I; Antunes E; Marcondes S
Platelets; 2012; 23(3):195-201. PubMed ID: 21806496
[TBL] [Abstract][Full Text] [Related]
27. [The role of guanyl cyclase in the regulation of aggregation of human thrombocytes].
Chirkov IuIu; Belushkina NN; Tyshchuk IA; Severina IS
Vestn Akad Med Nauk SSSR; 1991; (10):51-4. PubMed ID: 1686950
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of human platelet aggregation by nitric oxide donor drugs: relative contribution of cGMP-independent mechanisms.
Sogo N; Magid KS; Shaw CA; Webb DJ; Megson IL
Biochem Biophys Res Commun; 2000 Dec; 279(2):412-9. PubMed ID: 11118301
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of platelet aggregation by rat globin.
Singh MP; Sinha S; Raghavan SA; Dikshit M
Thromb Res; 2002 Sep; 107(5):201-7. PubMed ID: 12479879
[TBL] [Abstract][Full Text] [Related]
30. Acceleration of superoxide generation in polymorphonuclear leukocytes and inhibition of platelet aggregation by alk(en)yl thiosulfates derived from onion and garlic in dogs and humans.
Chang HS; Yamato O; Sakai Y; Yamasaki M; Maede Y
Prostaglandins Leukot Essent Fatty Acids; 2004 Jan; 70(1):77-83. PubMed ID: 14643182
[TBL] [Abstract][Full Text] [Related]
31. Human recombinant interleukin-1 beta induces thromboxane A2 release in polymorphonuclear leukocytes, macrophages and platelets: effect of IL-1 receptor antagonist.
Reale M; Barbacane RC; Frydas S; Anogianakis G; Trakatellis A; Dimitriadou D; Vacalis D; Placido FC; De Fazio P; Porreca E; Di Febbo C; Conti P
Mol Cell Biochem; 1996 Jun; 159(2):163-8. PubMed ID: 8858567
[TBL] [Abstract][Full Text] [Related]
32. Characterization of the L-arginine-NO-cGMP pathway in spontaneously hypertensive rat platelets: the effects of pregnancy.
Ognibene DT; Moss MB; Matsuura C; Brunini TM; de Moura RS; Mendes-Ribeiro AC; Resende AC
Hypertens Res; 2010 Sep; 33(9):899-904. PubMed ID: 20555333
[TBL] [Abstract][Full Text] [Related]
33. In vitro inhibition of human and rat platelets by NO donors, nitrosoglutathione, sodium nitroprusside and SIN-1, through activation of cGMP-independent pathways.
Priora R; Margaritis A; Frosali S; Coppo L; Summa D; Di Giuseppe D; Aldinucci C; Pessina G; Di Stefano A; Di Simplicio P
Pharmacol Res; 2011 Sep; 64(3):289-97. PubMed ID: 21539916
[TBL] [Abstract][Full Text] [Related]
34. Differential inhibition of human platelet aggregation and thromboxane A2 formation by L-arginine in vivo and in vitro.
Bode-Böger SM; Böger RH; Galland A; Frölich JC
Naunyn Schmiedebergs Arch Pharmacol; 1998 Feb; 357(2):143-50. PubMed ID: 9521487
[TBL] [Abstract][Full Text] [Related]
35. High glucose rapidly activates the nitric oxide/cyclic nucleotide pathway in human platelets via an osmotic mechanism.
Massucco P; Mattiello L; Russo I; Traversa M; Doronzo G; Anfossi G; Trovati M
Thromb Haemost; 2005 Mar; 93(3):517-26. PubMed ID: 15735804
[TBL] [Abstract][Full Text] [Related]
36. Antiplatelet effect of the anaesthetic drug propofol: influence of red blood cells and leucocytes.
De La Cruz JP; Páez MV; Carmona JA; De La Cuesta FS
Br J Pharmacol; 1999 Dec; 128(7):1538-44. PubMed ID: 10602334
[TBL] [Abstract][Full Text] [Related]
37. Moderate-intensity exercise suppresses platelet activation and polymorphonuclear leukocyte interaction with surface-adherent platelets under shear flow in men.
Wang JS; Liao CH
Thromb Haemost; 2004 Mar; 91(3):587-94. PubMed ID: 14983236
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of rat platelet aggregation by the diazeniumdiolate nitric oxide donor MAHMA NONOate.
Homer KL; Wanstall JC
Br J Pharmacol; 2002 Dec; 137(7):1071-81. PubMed ID: 12429580
[TBL] [Abstract][Full Text] [Related]
39. Matrix metalloproteinase 2 in tumor cell-induced platelet aggregation: regulation by nitric oxide.
Jurasz P; Sawicki G; Duszyk M; Sawicka J; Miranda C; Mayers I; Radomski MW
Cancer Res; 2001 Jan; 61(1):376-82. PubMed ID: 11196190
[TBL] [Abstract][Full Text] [Related]
40. Differentiation of cGMP-dependent and -independent nitric oxide effects on platelet apoptosis and reactive oxygen species production using platelets lacking soluble guanylyl cyclase.
Rukoyatkina N; Walter U; Friebe A; Gambaryan S
Thromb Haemost; 2011 Nov; 106(5):922-33. PubMed ID: 21800013
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]